Reimbursement scheme Intuniv®

General information

The pharmacist has dispensed Intuniv® 1, 2, 3 or 4mg to the patient. The health insurer will not reimburse the cost of this prescription in full. The producer of this medicine has therefore instructed TBR Nederland to reimburse to the patient the Personal Contribution charged.

Dose	1, 2, 3 and 4mg
Type	Tablets
Active ingredient	GUANFACINE

Reimbursement

Conditions

The Reimbursement Scheme Regulation of Intuniv® is limited to children and adolescents 6 to 17 years of age who are indicated for the treatment of attention deficit hyperactivity disorder (ADHD) for whom stimulants are unsuitable, are not well tolerated or have been demonstrated that they are not effective.

The Personal Contribution that is demonstrably charged to the patient by the health insurer for Intuniv® will be fully reimbursed from 1 January 2019 with a maximum of € 250 per patient per year. He / she can claim this at TBR Nederland.

Invoices with a date of issue in 2018 will be partially reimbursed. The patient pays € 40 of the Personal Contribution per pack of 28 tablets, regardless of the strength. He / she can claim the remaining costs at TBR Nederland.

Who can submit a claim

Patients or their carer can submit a claim online for the Personal Contribution amount they paid for Intuniv® 1, 2, 3 or 4mg. Pharmacists cannot submit claims on behalf of patients for this medicine.

Click here for detailed information about this reimbursement scheme and the way TBR Nederland works.

From when till when can you submit a claim

For this Reimbursement Scheme no closing date has been determined yet. Receipts with an issue date till 31 December 2018 can be submitted only by post, either by the pharmacist or the patient.